Larry E. Dillehay

Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.

Rajani Ravi, Bijoyesh Mookerjee, Zaver M. Bhujwalla et al. · PubMed · 2000 · 1.1K citations · Full text

Tumor Xenografts, Pathology, Cancer Biology +19

Disruption of p53 in human cancer cells alters the responses to therapeutic agents

Fred Bunz, Paul M. Hwang, Chris Torrance et al. · Journal of Clinical Investigation · 1999 · 1K citations · Full text

Medicine, Therapeutic Agents, Pharmacology +15

Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α

Rajani Ravi, Bijoyesh Mookerjee, Zaver M. Bhujwalla et al. · Genes & Development · 2000 · 951 citations · Full text

Hypoxia-inducible Factor 1α, Cancer Biology, Redox Biology +18

ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models

Cherrie K. Donawho, Yan Luo, Yanping Luo et al. · Clinical Cancer Research · 2007 · 762 citations · Full text

Cell-cycle arrest versus cell death in cancer therapy

Todd Waldman, Yonggang Zhang, Larry E. Dillehay et al. · Nature Medicine · 1997 · 386 citations

Cancer Therapy, Medicine, Metronomic Chemotherapy +5